iCureCeliac® is the only public celiac disease patient registry designed to help researchers better understand, and ultimately cure, celiac disease and non-celiac gluten/wheat sensitivity. iCureCeliac® allows patients to contribute medical information and their experiences living with celiac disease and non-celiac gluten/wheat sensitivity to advance life-changing initiatives in research, education, and advocacy. Your participation in iCureCeliac® will help discover new ways to improve patient lives through better diagnostic tools, treatments for cross-contact and gluten consumption, governmental policy changes, and access to new and innovative clinical trials nationwide, which may one day cure celiac disease.
7/10/2017
iCureCeliac® Reports 16 Month Progress
Recent Posts
- Policy Advocate: Pia Asthana's Celiac Story
- 2024 International Celiac Disease Symposium Recap
- Meet Our 2024 TCS New York City Marathon Team Gluten-Free Runners
- Biomarkers May Help Predict Celiac Disease in Patients with Type 1 Diabetes
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
9/26/2024
Read more2024 International Celiac Disease Symposium Recap
[video width="600" height="200" mp4="/wp-content/uploads/2024/09/ICDS-2024-header-recap.mp4" poster="/wp-content/uploads/2024/09/ICDS-2024-header-recap.jpg"][/video] Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with...